Mutual of America Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Mutual of America Capital Management’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$241K	Buy	+19,427	New	+$261K	﹤0.01%	1270

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Mutual of America Capital Management's AMRX Position: Q1 2026 in Review

Mutual of America Capital Management opened a new position in Amneal Pharmaceuticals (AMRX) in Q1 2026: 19,427 shares worth $241K. The stake represents ﹤0.01% of the portfolio and ranks #1270 among its holdings.

316 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

Mutual of America Capital Management held 19,427 shares of Amneal Pharmaceuticals worth $241K as of Q1 2026.
Amneal Pharmaceuticals was a new Mutual of America Capital Management position in Q1 2026.
Amneal Pharmaceuticals made up ﹤0.01% of Mutual of America Capital Management's portfolio in Q1 2026, its #1270 holding.
316 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on Mutual of America Capital Management's 13F filing for Q1 2026, filed 7 May 2026.